Сlinical consideration of «small signs» of the disease: necessity and art in the primary care physician activity in diagnostics of lifethreatining conditions (on the example of dermatological manifestations of HIV-infection)

##plugins.themes.bootstrap3.article.sidebar##

PDF (Українська)
Published: Mar 22, 2016
DOI: https://doi.org/10.30841/2307-5112.1(63).2016.102003
Keywords:
HIV infection, dermatological manifestations for HIV, human papillomavirus, primary care,

##plugins.themes.bootstrap3.article.main##

В. М. Рудіченко
Національний медичний університет імені О.О. Богомольця, м. Київ, Ukraine
А. О. Яновська
КНП «Центр первинної медико-санітарної допомоги No 2» Солом’янського району м. Києва, амбулаторія No 1, Ukraine

Abstract

The article presents literature data and clinical case concerning dermatological manifestations in HIV infection. Paradoxical situation is possible, when big scale of obvious skin disorders can be visible. But in case of the lack of other symptoms and disability, such disorders (eventually «small signs») are not considered as the signals of the danger. Primary and secondary manifestations of skin pathology connected to HIV-1 are given. In HIV-positive patients a lot of different types of papillomaviruses are possible. They can be divided into categories basing on the location, where they appeared (genital, skin), and as high or low risk basing on the potential of malignant proliferation. There is given a description of clinical case, when patient with HIV-infection before admittance to hospital practically did not pay special attention and did not inform medical staff about skin manifestations for a long period of time, causing lack of necessary medical attention and subsequent evaluation.

##plugins.themes.bootstrap3.article.details##

How to Cite
Рудіченко, В. М., & Яновська, А. О. (2016). Сlinical consideration of «small signs» of the disease: necessity and art in the primary care physician activity in diagnostics of lifethreatining conditions (on the example of dermatological manifestations of HIV-infection). Family Medicine, (1(63), 35–40. https://doi.org/10.30841/2307-5112.1(63).2016.102003
Issue
No. 1(63) (2016)
Section
For practicing physicians
Copyright (c) 2020 В. М. Рудіченко, А. О. Яновська

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors retain the copyright and grant the journal the first publication of original scientific articles under the Creative Commons Attribution 4.0 International License, which allows others to distribute work with acknowledgment of authorship and first publication in this journal.

Author Biographies

В. М. Рудіченко, Національний медичний університет імені О.О. Богомольця, м. Київ

В.М. Рудіченко

А. О. Яновська, КНП «Центр первинної медико-санітарної допомоги No 2» Солом’янського району м. Києва, амбулаторія No 1

А.О. Яновська

References

Кацупєєва А.О., Бондар І.С., Ротор М.Б., Сімовських Г.А. Клобаза – препарат вибору у лікуванні хворих на псоріаз // Тези доповідей міжнародної наукової конференції студентів та молодих вчених, присвячена 200-річчю з дня народження М.І. Пирогова, Одеса, 22–23.04.2010. – Одеса: Одеськ. держ. мед. ун-т, 2010. – С. 132.

Рудіченко В.М. Застосування дистанційних засобів телемедицини при викладанні англійською мовою у підготовці лікарів загальної практики–сімейної медицини // Матеріали Всеукраїнської навчально-наукової конференції з міжнародною участю, присвяченої пам’яті ректора, члена-кореспондента НАМН України, професора Л.Я. Ковальчука, «Реалізація Закону України «Про вищу освіту» у вищій медичній та фармацевтичній освіті України» (з дистанційним під’єднанням ВМ(Ф)НЗ України за допомогою відеоконференцзв’язку), Тернопіль, 21–22.05.2015. – Тернопіль: ТДМУ «Укрмедкнига», 2015. – С. 370.

Рудіченко В.М., Яновська А.О. Хвороба Рандю–Вебера–Ослера (спадкова геморагічна телеангіектазія) в загальній лікарській практиці: літературні дані, застосування інформаційно-комунікативних засобів телемедицини у викладанні державною та англійською мовами та власні клінічні спостереження // Сімейна медицина. – 2015. – No 1. – С. 34–39.

Amerio P., Verdolini R., Proietto G. et al. Role of Th2 cytokines,RANTES and eotaxin in AIDS-associated eosinophilic folliculitis // Acta Derm. Venereol. – 2001. – 81. – 92–95.

Antony F.C., Marsden R.A. Vitiligo in association with human immunodeficiency virus infection // J. Eur. Acad. Dermatol. Venereol. – 2003. – 17. – 456–458.

Armbruster-Moraes E., Ioshimoto L.M., Leao E. et al. Presence of human papillomavirus DNA in amniotic fluids of pregnant women with cervical lesions // Gynecol. Oncol. – 1994. – 54. – 152–158.

Bernstein W.B., Little R.F., Wilson W.H., Yarchoan R. Acquired immunodeficiency syndrome-related malignancies in the era of highly active antiretroviral therapy // Int. J. Hematol. – 2006. – 84. – 3–11.

Beutner K.R., Reitano M.V., Richwald G.A. et al. External genital warts: report of the American Medical Association Consensus Conference. AMA Expert Panel on External Genital Warts // Clin. Infect. Dis. – 1998. – 27. –796–806.

Bollen L.J., Chuachoowong R., Kilmarx P.H. et al. Human papillomavirus (HPV) detection among human immunodeficiency virus-infected pregnant Thai women: implications for future HPV immunization // Sex. Transm. Dis. – 2006. – 33. – 259–264.

Bonomo R.A., Korman N., Nagashima-Whalen L. et al. Pityriasis rubra pilaris: an unusual cutaneous complication of AIDS // Am. J. Med. Sci. – 1997. – 314. – 118–121.

Brown D.R., Shew M.L., Qadadri B. et al. A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women // J. Infect. Dis. – 2005. – 191. – 182–192.

Bull R.H., Fallowfield M.E., Marsden R.A. Autoimmune blistering diseases associated with HIV infection // Clin. Exp. Dermatol. – 1994. – 19. – 47–50.

Burchell A.N., Winer R.L., de Sanjosé S. et al. Epidemiology and transmission dynamics of genital HPV infection // Vaccine. – 2006. – 24(Suppl 3). – S52–S61.

Cedeno-Laurent F., Gómez-Flores M., Mendez N. et al. New insights into HIV-1-primary skin disorders // J. Int. AIDS Soc. – 2011. – 14. – 5–16.

Chan P.K., Chang A.R., Tam W.H. et al. Prevalence and genotype distribution of cervical human papillomavirus infection: comparison between pregnant women and non-pregnant controls // J. Med. Virol. – 2002. – 67. – 583–588.

Drobacheff C., Derancourt C., VanLanduyt H. et al. Porphyria cutanea tarda associated with human immunodeficiency virus infection // Eur. J. Dermatol. – 1998. – 8. – 492–496.

Fife K.H., Katz B.P., Brizendine E.J. et al. Cervical human papillomavirus deoxyribonucleic acid persists throughout pregnancy and decreases in the postpartum period // Am. J. Obstet. Gynecol. – 1999. – 180. – 1110–1114.

Frisch M., Biggar R.J., Goedert J.J. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome // J. Natl. Cancer. Inst. – 2000. – 92. – 1500–1510.

Gutman L.T., St Claire K., Herman-Giddens M.E. et al. Evaluation of sexually abused and nonabused young girls for intravaginal human papillomavirus infection // Am. J. Dis. Child. – 1992. – 146. – 694–699.

Hagensee M.E., Cameron J.E., Leigh J.E. et al. Human papillomavirus infection and disease in HIV-infected individuals // Am. J. Med. Sci. – 2004. – 328. – 57–63.

Hernandez-Giron C., Smith J.S., Lorincz A. et al. High-risk human papillomavirus detection and related risk factors among pregnant and nonpregnant women in Mexico // Sex. Transm. Dis. – 2005. – 32. – 613–618.

Ho G.Y., Bierman R., Beardsley L. et al. Natural history of cervicovaginal papillomavirus infection in young women // N. Engl. J. Med. – 1998. – 338. – 423–428.

Maurer T.A. Dermatologic manifestations of HIV infection // Top. HIV Med. – 2005. – 13. – 149–154.

Mofenson L.M., Brady M.T., Danner S.P. et al. Guidelines for the prevention and treatment of opportunistic infections among HIV-exposed and HIV-infected children: Recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics // M.M.W.R. Recomm. Rep. – 2009. – 58(RR-11). – 1–248.

Moscicki A., Burt V.G., Kanowitz S. et al. The significance of squamous metaplasia in the development of low grade squamous intraepithelial lesions in young women // Cancer. – 1999. – 85. – 1139–1144.

Moscicki A.B., Durako S.J., Houser J. et al. Human papillomavirus infection and abnormal cytology of the anus in HIV-infected and uninfected adolescents // AIDS. – 2003. – 17. – 311–320.

Moscicki A.B., Ellenberg J.H., Crowley-Nowick P. et al. Risk of high-grade squamous intraepithelial lesion in HIV-infected adolescents // J Infect. Dis. – 2004. – 190. – 1413–1421.

Moscicki A.B., Ellenberg J.H., Farhat S. et al. Persistence of human papillomavirus infection in HIV-infected and HIV-uninfected adolescent girls: risk factors and differences, by phylogenetic type // J. Infect. Dis. – 2004. – 190. – 37–45.

Moscicki A.B., Ellenberg J.H., Vermund S.H. et al. Prevalence of and risks for cervical human papillomavirus infection and squamous intraepithelial lesions in adolescent girls: impact of infection with human immunodeficiency virus // Arch. Pediatr. Adolesc. Med. – 2000. – 154. – 127–134.

Moscicki A.B., Hills N., Shiboski S. et al. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females // J. A. M. A – 2001. – 28. – 2995–3002.

Moscicki A.B., Schiffman M., Kjaer S. et al. Updating the natural history of HPV and anogenital cancer // Vaccine. – 2006. – 24(Suppl 3). – S42– S51.

Moscicki A.B., Shiboski S., Broering J. et al. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women // J. Pediatr. – 1998. – 132. – 277–284.

Munoz N., Castellsagué X., de González A.B. et al. Chapter 1: HPV in the etiology of human cancer // Vaccine. – 2006. – 24(Suppl 3). – S1–S10.

Munoz N., Méndez F., Posso H. et al. Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results // J. Infect. Dis. – 2004. – 190. – 2077–2087.

Munoz-Perez M.A., Rodriguez-Pichardo A., Camacho F., Colmenero M.A. Dermatological findings correlated with CD4 lymphocyte counts in a prospective 3 year study of 1161 patients with human immunodeficiency virus disease predominantly acquired through intravenous drug abuse // Br. J. Dermatol. – 1998. – 139. – 33–39.

Palefsky J. HPV infection and HPV-associated neoplasia in immunocompromised women // Int. J. Gynaecol. Obstet. – 2006. – 94(Suppl 1). – S56–S64.

Palefsky J., Holly E.A., Ralston M.L. et al. Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women // J. Infect. Dis. – 2001. – 183. – 383–391.

Perl A. Role of endogenous retroviruses in autoimmune diseases // Rheum. Dis. Clin. North. Am. – 2003. – 29. – 123–143.

Rintala M., Grénman S.E., Järvenkylä M.E. et al. High-risk types of human papillomavirus (HPV) DNA in oral and genital mucosa of infants during their first 3 years of life: experience from the Finnish HPV Family Study // Clin. Infect. Dis. – 2005. – 41. – 1728–1733.

Smith E.M., Ritchie J.M., Yankowitz J. et al. Human papillomavirus prevalence and types in newborns and parents: concordance and modes of transmission // Sex. Transm. Dis. – 2004. – 31. – 57–62.

Smith K.J., Skelton H.G., Tuur S. et al. Increased cutaneous toxicity to ionizing radiation in HIV-positive patients. Military Medical Consortium for the Advancement of Retroviral Research (MMCARR) // Int. J. Dermatol. – 1997. – 36. – 779–782.

Strickler H.D., Burk R.D., Fazzari M. et al. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women // J. Natl. Cancer Inst. – 2005. – 97. – 577–586.

Tarkowski T.A., Koumans E.H., Sawyer M. et al. Epidemiology of human papillomavirus infection and abnormal cytologic test results in an urban adolescent population // J. Infect. Dis. – 2004. – 189. – 46–50.

Tenti P., Zappatore R., Migliora P. et al. Perinatal transmission of human papillomavirus from gravidas with latent infections // Obstet. Gynecol. – 1999. – 93. – 475–479.

Toro J.R., Chu P., Yen T.S., LeBoit P.E. Granuloma annulare and human immunodeficiency virus infection // Arch. Dermatol. – 1999. – 135. – 1341–1346.

Tschachler E., Bergstresser P.R., Stingl G. HIV-related skin diseases // Lancet. – 1996. – 348. – 659-663.

Tseng C.J., Liang C.C., Soong Y.K. et al. Perinatal transmission of human papillomavirus in infants: relationship between infection rate and mode of delivery // Obstet. Gynecol. – 1998. – 91. – 92–96.

Tseng C.J., Lin C.Y., Wang R.L. et al. Possible transplacental transmission of human papillomaviruses // Am. J. Obstet. Gynecol. – 1992. – 166 (1 Pt 1). – 35–40.

Uthayakumar S., Nandwani R., Drinkwater T. et al. The prevalence of skin disease in HIV infection and its relationship to the degree of immunosuppression // Br. J. Dermatol. – 1997. – 137. – 595–598.

Winer R.L., Feng Q., Hughes J.P. et al. Risk of female human papillomavirus acquisition associated with first male sex partner // J. Infect. Dis. – 2008. – 197. – 279–282.

Winer R.L., Hughes J.P., Feng Q. et al. Condom use and the risk of genital human papillomavirus infection in young women // N. Engl. J. Med. – 2006. – 354. – 2645–2654.

Winer R.L., Lee S.K., Hughes J.P. et al. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students // Am. J. Epidemiol. – 2003. – 157. – 218–226.

Yarwood J.M., Leung D.Y., Schlievert P.M. Evidence for theinvolvement of bacterial superantigens in psoriasis, atopic dermatitis, and Kawasaki syndrome // F. E. M. S. Microbiol. Lett. – 2000. – 192. – 1–7.

Zalla M.J., Su W.P., Fransway A.F. Dermatologic manifestations of human immunodeficiency virus infection // Mayo Clin. Proc. – 1992. – 67. – 1089–1108.